CME Group (CME) Stock Price
CME Group Price
Revenue has compounded at 9.9% per year over the past 19 years to 6.52 B USD. Earnings per share have grown at 8.6% per year over the last 19 years. CME Group's net margin stands at 62.0%, up from 56.2% several years earlier. CME Group currently offers a dividend yield of about 1.87%. The payout ratio is around 45% of earnings. The dividend has grown at 3.7% per year over the past 19 years. Analysts set a median price target of 308.04 USD, implying 15.0% above the current price. Of 20 analysts, 11 rate the stock a buy — an overall Buy consensus. The stock trades about 22% above its 52-week low.
CME Group stock price
Details
Stock Price
ⓘHow to Read This Chart
This chart tracks the historical stock price of CME Group over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.
Total Return vs. Price Return
The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.
Intraday Price Data
When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how CME Group stock reacts to market openings, earnings releases, or breaking news throughout the trading session.
What to Look For
Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing CME Group's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.
| Date | CME Group Price |
|---|---|
| 7/31/2026 | 267.79 USD |
| 7/30/2026 | 267.22 USD |
| 7/29/2026 | 263.65 USD |
| 7/27/2026 | 256.23 USD |
| 7/23/2026 | 254.32 USD |
| 7/22/2026 | 249.24 USD |
| 7/21/2026 | 237.38 USD |
| 7/20/2026 | 245.11 USD |
| 7/17/2026 | 245.05 USD |
| 7/16/2026 | 246.27 USD |
| 7/15/2026 | 245.18 USD |
| 7/14/2026 | 243.61 USD |
| 7/13/2026 | 242.65 USD |
| 7/10/2026 | 240.27 USD |
| 7/9/2026 | 239.71 USD |
| 7/8/2026 | 243.43 USD |
| 7/7/2026 | 240.75 USD |
| 7/6/2026 | 234.82 USD |
| 7/2/2026 | 236.60 USD |
| 7/1/2026 | 231.00 USD |
| 6/30/2026 | 220.83 USD |
| 6/29/2026 | 218.90 USD |
| 6/26/2026 | 221.00 USD |
| 6/25/2026 | 225.00 USD |
| 6/24/2026 | 231.68 USD |
| 6/23/2026 | 242.26 USD |
| 6/22/2026 | 245.91 USD |
| 6/18/2026 | 253.12 USD |
| 6/17/2026 | 252.53 USD |
| 6/16/2026 | 256.50 USD |
| 6/15/2026 | 268.03 USD |
| 6/12/2026 | 266.20 USD |
| 6/11/2026 | 266.61 USD |
| 6/10/2026 | 261.27 USD |
| 6/9/2026 | 255.94 USD |
| 6/8/2026 | 252.03 USD |
| 6/5/2026 | 256.15 USD |
| 6/4/2026 | 255.76 USD |
| 6/3/2026 | 252.49 USD |
| 6/2/2026 | 247.17 USD |
| 6/1/2026 | 267.74 USD |
| 5/29/2026 | 279.70 USD |
| 5/28/2026 | 278.29 USD |
| 5/27/2026 | 277.99 USD |
| 5/26/2026 | 282.03 USD |
| 5/22/2026 | 291.02 USD |
| 5/21/2026 | 291.51 USD |
| 5/20/2026 | 294.02 USD |
| 5/19/2026 | 302.37 USD |
| 5/18/2026 | 305.12 USD |
| 5/15/2026 | 298.86 USD |
| 5/14/2026 | 297.70 USD |
| 5/13/2026 | 297.13 USD |
| 5/12/2026 | 285.75 USD |
| 5/11/2026 | 282.58 USD |
| 5/8/2026 | 281.25 USD |
| 5/7/2026 | 286.85 USD |
| 5/6/2026 | 288.34 USD |
| 5/5/2026 | 286.82 USD |
| 5/4/2026 | 290.29 USD |
| 5/1/2026 | 289.54 USD |
| 4/30/2026 | 287.82 USD |
| 4/29/2026 | 287.27 USD |
| 4/28/2026 | 284.53 USD |
| 4/27/2026 | 281.94 USD |
| 4/24/2026 | 285.06 USD |
| 4/23/2026 | 285.47 USD |
| 4/22/2026 | 285.71 USD |
| 4/21/2026 | 284.40 USD |
| 4/20/2026 | 287.45 USD |
| 4/17/2026 | 287.65 USD |
| 4/16/2026 | 296.22 USD |
| 4/15/2026 | 296.90 USD |
| 4/14/2026 | 297.03 USD |
| 4/13/2026 | 300.59 USD |
| 4/10/2026 | 295.30 USD |
| 4/9/2026 | 298.93 USD |
| 4/8/2026 | 302.81 USD |
| 4/7/2026 | 310.58 USD |
| 4/6/2026 | 308.57 USD |
| 4/5/2026 | 308.57 USD |
| 4/2/2026 | 305.11 USD |
| 4/1/2026 | 305.11 USD |
| 3/31/2026 | 296.94 USD |
| 3/30/2026 | 295.35 USD |
| 3/29/2026 | 297.58 USD |
| 3/27/2026 | 293.78 USD |
| 3/26/2026 | 293.78 USD |
| 3/25/2026 | 297.58 USD |
| 3/24/2026 | 293.93 USD |
| 3/23/2026 | 302.68 USD |
| 3/22/2026 | 306.56 USD |
| 3/20/2026 | 307.32 USD |
| 3/19/2026 | 307.32 USD |
| 3/18/2026 | 310.71 USD |
| 3/17/2026 | 308.90 USD |
| 3/16/2026 | 313.33 USD |
| 3/15/2026 | 313.83 USD |
| 3/13/2026 | 311.40 USD |
| 3/12/2026 | 311.40 USD |
| 3/11/2026 | 311.19 USD |
| 3/10/2026 | 303.33 USD |
| 3/9/2026 | 306.34 USD |
| 3/8/2026 | 319.09 USD |
| 3/6/2026 | 317.10 USD |
| 3/5/2026 | 316.81 USD |
| 3/4/2026 | 320.00 USD |
| 3/3/2026 | 325.13 USD |
| 3/2/2026 | 326.46 USD |
| 2/27/2026 | 319.50 USD |
| 2/26/2026 | 316.45 USD |
| 2/25/2026 | 307.36 USD |
| 2/24/2026 | 319.03 USD |
| 2/23/2026 | 314.00 USD |
| 2/20/2026 | 308.09 USD |
| 2/19/2026 | 303.91 USD |
| 2/18/2026 | 302.55 USD |
| 2/17/2026 | 303.23 USD |
| 2/13/2026 | 303.07 USD |
| 2/12/2026 | 301.96 USD |
| 2/11/2026 | 302.48 USD |
| 2/10/2026 | 306.76 USD |
| 2/9/2026 | 307.24 USD |
| 2/6/2026 | 302.27 USD |
| 2/5/2026 | 297.38 USD |
| 2/4/2026 | 294.62 USD |
| 2/3/2026 | 293.07 USD |
| 2/2/2026 | 290.77 USD |
| 1/30/2026 | 289.06 USD |
| 1/29/2026 | 289.83 USD |
| 1/28/2026 | 286.05 USD |
| 1/27/2026 | 284.48 USD |
| 1/26/2026 | 284.05 USD |
| 1/23/2026 | 282.74 USD |
| 1/22/2026 | 281.41 USD |
| 1/21/2026 | 279.07 USD |
| 1/20/2026 | 281.72 USD |
| 1/16/2026 | 279.52 USD |
| 1/15/2026 | 272.59 USD |
| 1/14/2026 | 275.23 USD |
| 1/13/2026 | 268.45 USD |
| 1/12/2026 | 264.98 USD |
| 1/9/2026 | 262.45 USD |
| 1/8/2026 | 266.64 USD |
| 1/7/2026 | 266.85 USD |
| 1/6/2026 | 269.15 USD |
| 1/5/2026 | 275.06 USD |
| 1/2/2026 | 269.68 USD |
| 12/31/2025 | 273.08 USD |
| 12/30/2025 | 275.83 USD |
| 12/29/2025 | 278.42 USD |
| 12/26/2025 | 276.73 USD |
| 12/24/2025 | 276.38 USD |
| 12/23/2025 | 275.53 USD |
| 12/22/2025 | 273.20 USD |
| 12/19/2025 | 269.09 USD |
| 12/18/2025 | 265.79 USD |
| 12/17/2025 | 273.74 USD |
| 12/16/2025 | 272.95 USD |
| 12/15/2025 | 272.18 USD |
| 12/12/2025 | 273.55 USD |
| 12/11/2025 | 272.41 USD |
| 12/10/2025 | 266.33 USD |
| 12/9/2025 | 270.12 USD |
| 12/8/2025 | 272.07 USD |
| 12/5/2025 | 270.87 USD |
| 12/4/2025 | 273.19 USD |
| 12/3/2025 | 274.34 USD |
| 12/2/2025 | 277.49 USD |
| 12/1/2025 | 278.99 USD |
| 11/28/2025 | 281.46 USD |
| 11/26/2025 | 282.54 USD |
| 11/25/2025 | 276.98 USD |
| 11/24/2025 | 275.68 USD |
| 11/21/2025 | 273.09 USD |
| 11/20/2025 | 275.01 USD |
| 11/19/2025 | 272.49 USD |
| 11/18/2025 | 279.28 USD |
| 11/17/2025 | 279.13 USD |
| 11/14/2025 | 285.04 USD |
| 11/13/2025 | 283.54 USD |
| 11/12/2025 | 279.58 USD |
| 11/11/2025 | 278.43 USD |
| 11/10/2025 | 277.28 USD |
| 11/7/2025 | 276.50 USD |
| 11/6/2025 | 272.02 USD |
| 11/5/2025 | 267.87 USD |
| 11/4/2025 | 267.85 USD |
| 11/3/2025 | 263.82 USD |
| 10/31/2025 | 265.37 USD |
| 10/30/2025 | 267.62 USD |
| 10/29/2025 | 261.53 USD |
| 10/28/2025 | 266.33 USD |
| 10/27/2025 | 270.42 USD |
| 10/24/2025 | 269.27 USD |
| 10/23/2025 | 268.90 USD |
| 10/22/2025 | 267.81 USD |
| 10/21/2025 | 268.28 USD |
| 10/20/2025 | 267.62 USD |
| 10/17/2025 | 267.77 USD |
| 10/16/2025 | 264.02 USD |
| 10/15/2025 | 268.15 USD |
| 10/14/2025 | 267.18 USD |
| 10/13/2025 | 271.28 USD |
| 10/10/2025 | 271.47 USD |
| 10/9/2025 | 268.69 USD |
| 10/8/2025 | 264.94 USD |
| 10/7/2025 | 263.32 USD |
| 10/6/2025 | 262.05 USD |
| 10/3/2025 | 265.02 USD |
| 10/2/2025 | 265.62 USD |
| 10/1/2025 | 265.82 USD |
| 9/30/2025 | 270.19 USD |
| 9/29/2025 | 272.24 USD |
| 9/28/2025 | 272.24 USD |
| 9/25/2025 | 270.28 USD |
| 9/24/2025 | 268.73 USD |
| 9/23/2025 | 261.96 USD |
| 9/22/2025 | 261.17 USD |
| 9/19/2025 | 261.67 USD |
| 9/18/2025 | 260.59 USD |
| 9/17/2025 | 262.40 USD |
| 9/16/2025 | 259.83 USD |
| 9/15/2025 | 259.15 USD |
| 9/12/2025 | 261.72 USD |
| 9/11/2025 | 262.38 USD |
| 9/10/2025 | 259.91 USD |
| 9/9/2025 | 261.53 USD |
| 9/8/2025 | 262.58 USD |
| 9/5/2025 | 261.96 USD |
| 9/4/2025 | 267.43 USD |
| 9/3/2025 | 269.35 USD |
| 9/2/2025 | 265.40 USD |
| 8/29/2025 | 266.53 USD |
| 8/28/2025 | 266.77 USD |
| 8/27/2025 | 270.12 USD |
| 8/26/2025 | 271.61 USD |
| 8/25/2025 | 271.39 USD |
| 8/22/2025 | 269.54 USD |
| 8/21/2025 | 273.32 USD |
| 8/20/2025 | 274.61 USD |
| 8/19/2025 | 271.49 USD |
| 8/18/2025 | 270.41 USD |
| 8/15/2025 | 273.21 USD |
| 8/14/2025 | 274.70 USD |
| 8/13/2025 | 273.92 USD |
| 8/12/2025 | 275.88 USD |
| 8/11/2025 | 285.42 USD |
| 8/8/2025 | 283.02 USD |
| 8/7/2025 | 280.95 USD |
| 8/6/2025 | 281.35 USD |
| 8/5/2025 | 284.61 USD |
| 8/4/2025 | 287.10 USD |
CME Group Revenue, EBIT, Net Income
3 Years
5 Years
10 Years
25 Years
Max
Details
CME Group Income Statement, Balance Sheet, Cash Flow Statement
| REVENUEB USD |
|---|
| REVENUE GROWTH% |
| GROSS MARGIN% |
| GROSS INCOMEB USD |
| EBITB USD |
| EBIT MARGIN% |
| NET INCOMEB USD |
| NET INCOME GROWTH% |
| DIVIDENDDIV.USD |
| DIVIDEND GROWTHDIV. GROWTH% |
| SHARESM |
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026e | 2027e | 2028e | 2029e | 2030e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3.33 | 3.60 | 3.64 | 4.31 | 4.87 | 4.88 | 4.69 | 5.02 | 5.58 | 6.13 | 6.52 | 7.03 | 7.38 | 7.86 | 8.46 | 8.73 |
| 6.88 | 8.09 | 1.36 | 18.25 | 12.97 | 0.31 | -3.97 | 7.04 | 11.14 | 9.90 | 6.36 | 7.79 | 5.05 | 6.47 | 7.59 | 3.22 |
| 82.53 | 84.90 | 84.52 | 84.40 | 81.53 | 82.47 | 82.15 | 85.00 | 85.16 | 86.12 | 86.09 | 86.09 | 86.09 | 86.09 | 86.09 | 86.09 |
| 2.75 | 3.05 | 3.08 | 3.64 | 3.97 | 4.03 | 3.85 | 4.27 | 4.75 | 5.28 | 5.61 | 6.05 | 6.36 | 6.77 | 7.28 | 7.52 |
| 1.99 | 1.15 | 1.52 | 1.42 | 1.06 | 2.89 | 2.81 | 3.65 | 3.60 | 4.70 | 5.45 | 6.31 | 6.63 | 7.05 | 7.59 | 7.83 |
| 59.77 | 31.88 | 41.63 | 32.95 | 21.77 | 59.14 | 59.97 | 72.78 | 64.45 | 76.70 | 83.51 | 89.74 | 89.73 | 89.73 | 89.74 | 89.73 |
| 1.25 | 1.53 | 4.06 | 1.96 | 2.12 | 2.11 | 2.64 | 2.69 | 3.23 | 3.53 | 4.04 | 4.42 | 4.66 | 5.00 | 5.41 | 5.79 |
| 10.65 | 23.02 | 164.86 | -51.71 | 7.85 | -0.52 | 25.23 | 2.09 | 19.88 | 9.27 | 14.72 | 9.25 | 5.48 | 7.27 | 8.14 | 7.05 |
| 4.90 | 8.90 | 6.14 | 4.55 | 5.50 | 5.90 | 6.85 | 8.50 | 9.65 | 10.40 | 5.00 | 5.20 | 5.20 | 5.20 | – | – |
| 26.29 | 81.63 | -31.01 | -25.90 | 20.88 | 7.27 | 16.10 | 24.09 | 13.53 | 7.77 | -51.92 | 4.00 | – | – | – | – |
| 338.25 | 339.34 | 340.49 | 352.13 | 358.35 | 358.61 | 359.02 | 359.19 | 359.69 | 360.05 | 360.23 | 360.23 | 360.23 | 360.23 | 360.23 | 360.23 |
Details
Income Statement Key Figures
ⓘRevenue and Revenue Growth
Revenue is the starting point of every income statement — it measures the total sales CME Group generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.
Gross Margin
Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue CME Group retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare CME Group's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.
EBIT and EBIT Margin
EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.
Net Income and Earnings Per Share (EPS)
Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.
Shares Outstanding
The total number of shares CME Group has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.
Analyst Estimates
The projected figures represent consensus estimates from professional analysts. Compare these forecasts against CME Group's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.
CME Group stock margins
3 Years
5 Years
10 Years
25 Years
Max
Details
CME Group Stock Revenue, EBIT, Earnings per Share
3 Years
5 Years
10 Years
25 Years
Max
Details
CME Group business model & stock analysis
CME Group SWOT Analysis
Strengths
CME Group Inc has a leading position in the global derivatives and options market, providing a diverse range of products and services.
The strong brand recognition and reputation of CME Group Inc help in attracting customers and maintaining market share.
The company benefits from advanced technology infrastructure, enabling efficient and reliable trading operations.
Weaknesses
CME Group Inc is highly dependent on market conditions, making it vulnerable to economic downturns and fluctuations in trading volumes.
The company faces intense competition from other exchanges, which may impact its market position and pricing power.
Limited diversification of its revenue streams makes CME Group Inc susceptible to risks associated with its core business.
Opportunities
Expansion into new geographical markets, particularly emerging economies, can provide growth opportunities for CME Group Inc.
The increasing demand for risk management tools and hedging instruments creates opportunities for the company to introduce innovative products.
Strategic partnerships and acquisitions can help CME Group Inc strengthen its market position and expand its product portfolio.
Threats
Regulatory changes and government policies can impact the operations and profitability of CME Group Inc.
The emergence of new technologies and competitors in the financial services industry poses a threat to the company's market share.
Fluctuations in interest rates and currency exchange rates can affect the financial performance of CME Group Inc.
CME Group Employees
3 Years
5 Years
10 Years
25 Years
Max
Details
CME Group Segments
CME Group Revenue by Segment
3 Years
5 Years
Max
Details
CME Group Eulerpool Fair Value
Details
Fair Value Estimate
ⓘWhat Is Fair Value?
Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.
Earnings-Based Fair Value
Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.
Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021
Revenue-Based Fair Value
Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"
Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021
Dividend-Based Fair Value
Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.
Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021
How to Use This Chart
When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.
CME Group historical P/E ratio, EBIT multiple, and P/S ratio
CME Group annual returns
Details
Annual Return
ⓘWhat This Chart Shows
This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.
Price Return
Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.
Dividend Return
Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.
What to Look For
Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.
CME Group shares outstanding
3 Years
5 Years
10 Years
25 Years
Max
Details
CME Group stock splits
CME Group Dividend History
24 years of dividend payments
CME Group dividend history and estimates
3 Years
5 Years
10 Years
25 Years
Max
Details
CME Group dividend payout ratio
3 Years
5 Years
10 Years
25 Years
Max
Details
Current CME Group forecasts and price targets in August 2026
Analyst Price Targets 2026CME Group Analyst Rating Actions
| Date | Firm | Action | Rating | Reliability |
|---|---|---|---|---|
| 7/23/2026 | Maintained | Overweight | 60 | |
| 7/23/2026 | Maintained | Underweight | 80 | |
| 7/23/2026 | Maintained | Underperform | 70 | |
| 7/15/2026 | Maintained | Overweight | 51 | |
| 7/10/2026 | Maintained | Overweight | 60 | |
| 7/9/2026 | Maintained | Equal Weight | 33 | |
| 7/8/2026 | Maintained | Buy | 60 | |
| 7/6/2026 | Maintained | Neutral | 51 | |
| 7/2/2026 | Maintained | Outperform | 74 | |
| 6/22/2026 | Maintained | Buy | 60 |
Eulerpool Reliability Score (0–100): measures how often a firm’s bullish or bearish calls were directionally correct three months later, blended with the average return following its calls. Every rating we record is stored permanently and scores update continuously; firms with fewer than 3 measured calls are not scored yet.
CME Group Earnings Calls
CME Group Earnings Estimates & Surprises
| Date | EPS estimate | EPS Actual | Revenue Estimate | Price reaction | Quarterly report |
|---|---|---|---|---|---|
| 7/22/2026 | 3.02USD | - | 1.74 BUSD | - | 2026 Q2 |
| 4/22/2026 | 3.20USD | - | 1.82 BUSD | - | 2026 Q1 |
| 2/4/2026 | 2.77USD | - | 1.67 BUSD | - | 2025 Q4 |
| 4/24/2024 | 2.39USD | - | 1.47 BUSD | - | 2024 Q1 |
| 2/6/2024 | 2.22USD | - | 1.40 BUSD | - | 2023 Q4 |
| 7/25/2023 | 2.09USD | - | 1.30 BUSD | - | 2023 Q2 |
| 4/25/2023 | 2.16USD | - | 1.36 BUSD | - | 2023 Q1 |
| 2/7/2023 | 1.95USD | - | 1.25 BUSD | - | 2022 Q4 |
| 10/26/2022 | 1.96USD | - | 1.24 BUSD | - | 2022 Q3 |
| 7/27/2022 | 1.95USD | - | 1.26 BUSD | - | 2022 Q2 |
EESG©
Eulerpool ESG Scorecard© for the CME Group stock
EEnvironment
20
Environment
SSocial
20
Social
GGovernance (Corporate Governance)
4
Governance (Corporate Governance)
The Eulerpool ESG Scorecard© is the strictly copyrighted intellectual property of Eulerpool Research Systems. Any unauthorized use, imitation, or infringement will be actively pursued and may lead to significant legal consequences. For licenses, collaborations, or usage rights, please contact us directly via our contact form. Contact Form to us.
CME Group shareholder structure
| % | Name |
|---|---|
8.72109% | |
6.48011% | |
4.45238% | |
3.38596% | |
2.60866% | |
2.53657% |
CME Group Beneficial Ownership Filings (SEC 13D/G)
| Stake | Holder | Filing |
|---|---|---|
13.70% | SEC ↗ | |
11.00% | SEC ↗ | |
10.00% | SEC ↗ | |
9.30% | SEC ↗ | |
8.72% | SEC ↗ | |
7.45% | SEC ↗ | |
6.70% | SEC ↗ | |
6.13% | SEC ↗ | |
6.13% | SEC ↗ | |
4.60% | SEC ↗ |
CME Group Executives and Management Board
29 members · avg. age 59 · 31 % women
Hon. Terrence Duffy (66)
Executive Chairman of the Board, Chief Executive Officer · since 1995
23.95 M USD
Management
Ms. Lynne Fitzpatrick (45)
President, Chief Financial Officer
Mr. Derek Sammann (56)
Senior Managing Director - Global Head of Commodities Markets
Ms. Julie Winkler (50)
Chief Commercial Officer
Mr. Sunil Cutinho (53)
Chief Information Officer
Mr. Michael Dennis (44)
Senior Managing Director - Global Head, Fixed Income · since 2020
Ms. Suzanne Sprague (44)
Chief Operating Officer and Global Head of Clearing
Board of Directors
Mr. William Shepard (78)
Independent Director · since 1997
Mr. Timothy Bitsberger (65)
Independent Director
Mr. Charles Carey (71)
Non-Executive Independent Vice Chairman of the Board · since 2007
Mr. William Hobert (61)
Independent Director
Ms. Phyllis Lockett (59)
Independent Director
Mr. Daniel Kaye (70)
Independent Director · since 2019
CME Group Supply Chain
CME Group Supply Chain
Correlation: how closely stock prices move together
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | 0.81 | 0.65 | 0.86 | ||
| 2 | 0.48 | -0.01 | 0.75 | ||
| 3 | -0.15 | 0.20 | 0.72 | ||
| 4 | 0.83 | -0.03 | 0.71 | ||
| 5 | 0.42 | -0.03 | 0.60 |
| # | Name | Trend | |||
|---|---|---|---|---|---|
| 1 | Japan Exchange Group, Inc. | — | — | — | |
| 2 | -0.23 | 0.36 | — | ||
| 3 | SEC Newgate S.p.A. | -0.64 | -0.53 | — | |
| 4 | 0.22 | 0.70 | — | ||
| 5 | Singapore Exchange Limited | 0.17 | -0.67 | — |
Frequently asked questions about CME Group
The business model of CME Group Inc is centered around operating a global marketplace for derivatives, options, and futures contracts. As the world's largest futures exchange, CME Group facilitates trading across multiple asset classes, including agricultural products, energy, metals, interest rates, and equity indexes. It provides a platform for market participants to manage price risks, access liquidity, and enhance portfolio diversification. CME Group's business model relies on offering innovative trading products, robust risk management tools, and technologically advanced trading platforms to serve the needs of a diverse range of market participants, such as institutional investors, corporations, and individual traders.
CME Group Inc is primarily active in the financial industry.
CME Group Inc faces competition from various players in the market. Some of the main competitors include Intercontinental Exchange (ICE), Nasdaq, and Chicago Board Options Exchange (CBOE). These competitors also operate in the global derivatives exchange and clearing industry, offering similar products and services. However, CME Group Inc's leading position, diverse product range, and extensive market reach enable it to maintain a competitive edge in the industry.
CME Group Inc, founded in 1898 as Chicago Butter and Egg Board, has a rich history and a prominent position in the financial industry. Over the years, the company expanded its offerings and acquired several other exchanges, including the Chicago Mercantile Exchange and the New York Mercantile Exchange. Today, CME Group is the world's leading and most diverse derivatives marketplace, facilitating trading across various asset classes, including futures, options, and derivatives. With a strong focus on innovation and technology, CME Group continues to provide global customers with reliable and transparent markets, enabling them to manage risk and achieve their financial goals efficiently.
CME Group Inc, a renowned financial market corporation, has achieved significant milestones throughout its existence. The company has demonstrated remarkable growth and success, becoming the world's largest futures exchange operator. CME Group has expanded its offerings by introducing innovative products and technology, continually enhancing market efficiency and providing reliable risk management solutions to market participants. With its merger in 2007, CME Group created a global powerhouse, enabling seamless trading and clearing across multiple asset classes. CME Group's commitment to driving industry advancement has resulted in numerous accolades, solidifying its reputation as a leader in the global financial industry.
CME Group Inc is primarily present in various countries and regions worldwide. Its presence spans across the United States, with its headquarters in Chicago, Illinois. Additionally, CME Group has a significant presence in Europe, particularly in London and Belfast. The company also maintains offices and operations in Asia, specifically in Singapore and Tokyo. With its global reach, CME Group Inc serves as a leading financial exchange, connecting market participants from around the world and offering a diverse range of derivatives and futures products.
CME Group Inc represents a steadfast commitment to integrity, innovation, and collaboration. Known as the leading derivatives marketplace, CME Group fosters a transparent and trusted environment for global financial markets. With a focus on providing reliable risk management solutions, CME Group empowers market participants to manage their portfolios efficiently. The company's philosophy revolves around driving market efficiency while ensuring fairness and equal access to all participants. CME Group's dedication to customer-centric solutions, technological advancements, and industry-leading expertise solidifies its position as a trusted partner in the ever-evolving financial landscape.
Analysts currently set an average price target of 297.93 USD for the CME Group stock (median: 308.04 USD), implying +11.3 % versus the latest price. The consensus is based on 20 analyst ratings.
20 analysts currently rate the CME Group stock: 11 recommend buying, 6 holding and 3 selling. For 2026, analysts expect CME Group to generate revenue of 7.03 B USD and earnings per share of 12.27 USD.
Converted at the current exchange rate, the CME Group share trades at 232.63 EUR (267.79 USD).
The CME Group share (CME) is listed on 9 stock exchanges, including: NASDAQ (CME), XETRA (MX4A.DE), Frankfurt (MX4A.F), München (MX4A.MU), Düsseldorf (MX4A.DU), London (0HR2.L), London (0HR2.L), SIX (Zürich) (MX4A.SW).
The CME Group Inc is one of the world's leading companies in the derivatives exchange sector. Its business model is based on trading futures and options on commodities, stock indices, interest rates, and currencies on the exchanges of Chicago and New York. The CME Group offers a wide range of financial products that enable its customers to hedge risks or speculate on the price movements of assets. The products offered include futures contracts, options contracts, swap contracts, and other complex derivative instruments. The CME Group is divided into four business segments: first, there is the agricultural commodities segment, where futures on corn, wheat, soybeans, and other agricultural products are traded, for example. The energy segment includes futures and options on natural gas, oil, and electricity. The metals and minerals segment offers futures and options on gold, silver, copper, and other precious metals. Finally, there is the interest rates and currencies segment, where futures and options on various currencies and interest rates are traded. In addition to offering financial products, the CME Group also provides various services, such as data and information services and clearing services. In this context, it also operates clearing houses that settle transactions between customers, clear them in real-time, and thereby minimize risk for all parties involved. To serve its customers in the best possible way, the CME Group has also developed several platforms. The Global Command Center (GCC) is one of the most advanced trading platforms in the world and offers an optimal data- and information-based trading environment while also providing complex analysis functions to its customers. In recent years, the CME Group has become a leading provider in the derivatives exchange sector. Its innovative technology and efficient transaction processing, as well as the high quality of its products and services, have contributed to an increase in trading volumes. Today, leading financial institutions, hedge funds, companies, and individual investors trade at the CME Group, which repeatedly sets standards through its market-dominating position.
The expected revenue of CME Group is 7.03 B USD. This figure is based on current financial data and reflects the company's business performance.
The expected profit of CME Group is 4.42 B USD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of CME Group is currently 21.83. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the CME Group stock.
The price-to-sales ratio (P/S) of CME Group is currently 13.72. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the CME Group stock.
The Eulerpool Quality Score for CME Group is 7/10.
The ISIN of CME Group is US12572Q1058. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of CME Group is A0MW32. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of CME Group is CME. The ticker symbol is used to trade CME Group shares on the stock exchange.
Over the past 12 months, CME Group paid a dividend of 5.00 USD . This corresponds to a dividend yield of about 1.87 %. For the coming 12 months, CME Group is expected to pay a dividend of 5.20 USD.
The current dividend yield of CME Group is 1.87 %.
CME Group pays a dividend, distributed in the months of , , , .
CME Group paid dividends every year for the past 23 years.
For the upcoming 12 months, dividends amounting to 5.20 USD are expected. This corresponds to a dividend yield of 1.94 %.
CME Group is assigned to the 'Finance' sector.
To receive the latest dividend of CME Group from amounting to 1.3 USD, you needed to have the stock in your portfolio before the ex-date on .
The last dividend was paid out on .
In the year 2025, CME Group distributed 10.4 USD as dividends.
The dividends of CME Group are distributed in USD.
CME Group stock
CME Group Peer Group
CME Group Ticker
CME Group FIGI
All fundamentals and in-depth analysis of CME Group
Our stock analysis for CME Group stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of CME Group. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.